At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Public ClinicalTrials.gov record NCT05969860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic
Study identification
- NCT ID
- NCT05969860
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Mayo Clinic
- Other
- Enrollment
- 220 participants
Conditions and interventions
Conditions
- Advanced Anal Carcinoma
- Advanced Appendix Carcinoma
- Advanced Basal Cell Carcinoma
- Advanced Biliary Tract Carcinoma
- Advanced Bladder Carcinoma
- Advanced Breast Carcinoma
- Advanced Carcinoid Tumor
- Advanced Cervical Carcinoma
- Advanced Cholangiocarcinoma
- Advanced Colorectal Carcinoma
- Advanced Endometrial Carcinoma
- Advanced Esophageal Carcinoma
- Advanced Fallopian Tube Carcinoma
- Advanced Gastric Carcinoma
- Advanced Gastroesophageal Junction Adenocarcinoma
- Advanced Glioblastoma
- Advanced HER2 Positive Breast Carcinoma
- Advanced Head and Neck Carcinoma
- Advanced Hepatocellular Carcinoma
- Advanced Liver Carcinoma
- Advanced Lung Carcinoma
- Advanced Lung Small Cell Carcinoma
- Advanced Lymphoma
- Advanced Malignant Germ Cell Tumor
- Advanced Malignant Solid Neoplasm
- Advanced Malignant Testicular Neoplasm
- Advanced Melanoma
- Advanced Merkel Cell Carcinoma
- Advanced Neuroendocrine Carcinoma
- Advanced Ovarian Carcinoma
- Advanced Pancreatic Carcinoma
- Advanced Penile Carcinoma
- Advanced Primary Malignant Central Nervous System Neoplasm
- Advanced Prostate Carcinoma
- Advanced Prostate Small Cell Neuroendocrine Carcinoma
- Advanced Renal Cell Carcinoma
- Advanced Sarcoma
- Advanced Skin Squamous Cell Carcinoma
- Advanced Urethral Carcinoma
- Advanced Vaginal Carcinoma
- Advanced Vulvar Carcinoma
- Hematopoietic and Lymphoid System Neoplasm
- Multiple Myeloma
- Myelodysplastic Syndrome
Interventions
- Clinical Encounter Procedure
- Home Health Encounter Other
- Quality-of-Life Assessment Other
- Questionnaire Administration Other
Procedure · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 22, 2023
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
- Last update posted
- Apr 19, 2026
2023 – 2027
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | Recruiting |
| Altru Cancer Center | Grand Forks | North Dakota | 58201 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05969860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05969860 live on ClinicalTrials.gov.